All News
Filter News
Found 287 articles
-
After a “reasonably strong year” in 2023, next year will see “similar levels” of M&A activity with increased investor interest in weight loss and cardiovascular diseases, contends professional services firm PwC.
-
What to Do After You’ve Been Laid Off
12/14/2023
Being laid off from a job is stressful. Fortunately, there are steps you can take to curb some of that stress, relieve financial worries and make finding your next position as smooth a process as possible. -
How to Address a Layoff in Your Cover Letter
12/14/2023
Being laid off from your job can be difficult and confusing. To help you in your job search, we've explained how to address a layoff in your cover letter to help you land your dream job. -
Although looking for candidates on platforms like LinkedIn continues to be the norm, some headhunters are also combing Google Scholar and PubMed for authors with relevant skills.
-
This week, in (our inaugural episode!) BioSpace's Greg Slabodkin, Tyler Patchen and Lori Ellis discuss the good, the bad and the ugly of biopharma's reported Q3 earnings. They also tackle what's going on at Pfizer, ADCs, deals and more.
-
A recent report by Tufts Medical Center reveals impressive approval rates for durable cell and gene therapies, but experts urge caution over persistent safety and accessibility concerns.
-
The biotech venture capital firm, led by former Andreessen Horowitz senior partner Kouki Harasaki, emerged from stealth on Wednesday focused on investing in companies with first-in-class or best-in-class therapies.
-
Third-quarter revenues for antiviral treatment Paxlovid dropped 97% operationally compared with the prior-year period, while vaccine Comirnaty revenues declined 70% in the quarter.
-
In a cooling job market, companies often can’t match job seekers’ expectations on factors such as salary and remote work.
-
In its most recent round of layoffs this year, the California-based biopharma company is letting go of 350 former Horizon Therapeutics staff whose roles overlap with existing positions at Amgen.
-
Nephron Announces Hiring of Key Executives
10/24/2023
Nephron Pharmaceuticals Corporation announced the new hiring of six key executives.
-
Avenacy Launches to Deliver Critical Medications
10/23/2023
venacy, a specialty pharmaceutical company focused on developing, manufacturing, and delivering critical medications, announced its launch.
-
The layoffs, set to take effect in late November, will impact about a third of Reata’s headcount. The workforce reduction comes just weeks after Biogen completed its $7.3 billion Reata buy.
-
The biotech is laying off about 29% of its employees and will focus its resources on the company’s hypoimmune platform. The latest downsizing follows a previous round of layoffs in August 2023.
-
While grappling with financial challenges, the biotech industry is forced to pivot to flexible business models.
-
Boehringer Ingelheim will launch three Phase III studies for its obesity drug candidate; third time is a charm for Ipsen as it gets FDA approval; and Pfizer takes multiple myeloma battle to J&J.
-
Employers in the industry find they need to offer perks such as higher pay, more impressive job titles and hybrid or remote work to stay competitive.
-
The FDA approved Sage and Biogen’s zuranolone Friday as the first oral medication for postpartum depression but declined to approve the application in major depressive disorder.
-
Viracta Therapeutics Appoints Darrel P. Cohen, M.D., Ph.D. as Chief Medical Officer
8/7/2023
Viracta Therapeutics, Inc. today announced the appointment of Darrel P. Cohen, M.D., Ph.D. as Chief Medical
-
The industry may not have fully rebounded to the highs seen a couple of years ago, but there are sure signs of spring in the air.